USE CASES External Control Arms REGULATORY RESEARCH External Control Arms for Timely Drug Approvals ConcertAI’s deep, custom abstraction of patient real-world data and decades of scientific expertise helps clients through the regulatory process of designing and submitting successful External Control Arms. Request a Demo Regulatory-Grade Linked Claims, Genomics Datasets Full-Service Consultation Custom Abstraction of Specific Variables Reasons for External Control Arms Request a Demo RARE CANCERS COMPETITIVE TRIAL SPACE PATIENT CRITERIA TRIAL COMPLETION Clinical trials are expensive and challenging in ordinary times. COVID-19 has made this situation much more difficult, negatively impacting clinical trial activities and delaying life-saving treatments. In response, the FDA has acted recently to create an environment to encourages novel trial designs where external control arms can thrive. View Full Infographic Pre-Approval Post-Approval Inform clinical trial design and feasibility with our interactive cohort matching tool Conduct propensity score matching or frequency matching with demographic and clinical characteristics matched to clinical trial patients Rescue underperforming trials when the RCT is having difficultly accruing patients in a standard of care cohort Satisfy market requirements for fast-tracked, breakthrough applications or newly approved treatments coming to market with limited comparative data External control arms use real-world data (RWD) to enhance data from single-arm trials. They can speed up patient accrual and reduce costs. Results include: 50% reduction in patient accrual needs Ability meet fast-tracked designation timelines Increased trial efficiency Reduced site and patient burden Decreased risk View Full Infographic Working with a one-stop partner for deep, reliable RWD and expert research and analytics services can lead to: Timely Treatment Assessments Faster Drug Approvals Reduced Site and Patient Burden Customer Value for External Control Arms Request Demo CLINICAL DEVELOPMENT LEADERS HEOR, MARKET ACCESS AND MEDICAL AFFAIRS EXECUTIVES EPIDEMIOLOGISTS TRANSLATIONAL MEDICINE LEADERS Use Cases Commercial Solutions Study Design Regulatory Use External Control Arms AML Bladder Breast Gastric-Esophageal Lung Liver Melanoma Pancreatic Prostate Renal All Other Cancers Products & Services Data Products Predictive Patient STAR SPRINT Services Research Publications ERACE Resources Content Webinars and Events News Blog About Us Our Team Careers Investors Contact Us Request a Demo © 2017-2021 ConcertAI. All Rights Reserved. ConcertAI is a SymphonyAI company. Privacy Policy Terms of Use Privacy Policy Accept